Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127216061 | 12721606 | 1 | I | 20160823 | 20160907 | 20160907 | EXP | US-IPCA LABORATORIES LIMITED-IPC201609-000753 | IPCA | BAZARI H,PALMER W,BARON J,ARMSTRONG K. CASE 24-2016: A 66-YEAR-OLD MAN WITH MALAISE, WEAKNESS, AND HYPERCALCEMIA. N ENGL J MED 2016 AUG 11;375(6):567-74. | 66.00 | YR | M | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127216061 | 12721606 | 1 | PS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 40807 | |||||||||||
| 127216061 | 12721606 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | |||||||||||
| 127216061 | 12721606 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
| 127216061 | 12721606 | 4 | SS | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | U | 0 | |||||||||||
| 127216061 | 12721606 | 5 | SS | NAPROXEN. | NAPROXEN | 1 | U | 0 | |||||||||||
| 127216061 | 12721606 | 6 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127216061 | 12721606 | 7 | C | Tadalafil | TADALAFIL | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 8 | C | Glucosamine | GLUCOSAMINE | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 9 | C | DISULFIRAM. | DISULFIRAM | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 10 | C | Tamsulosin | TAMSULOSIN | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 11 | C | N-3 fatty acids | 2 | 0 | |||||||||||||
| 127216061 | 12721606 | 12 | C | Cyclobenzaprine | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127216061 | 12721606 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127216061 | 12721606 | 1 | Dyspepsia |
| 127216061 | 12721606 | 2 | Musculoskeletal discomfort |
| 127216061 | 12721606 | 3 | Dyspepsia |
| 127216061 | 12721606 | 4 | Dyspepsia |
| 127216061 | 12721606 | 5 | Musculoskeletal disorder |
| 127216061 | 12721606 | 6 | Musculoskeletal discomfort |
| 127216061 | 12721606 | 8 | Musculoskeletal disorder |
| 127216061 | 12721606 | 10 | Musculoskeletal disorder |
| 127216061 | 12721606 | 11 | Musculoskeletal disorder |
| 127216061 | 12721606 | 13 | Mineral supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127216061 | 12721606 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127216061 | 12721606 | Acute kidney injury | |
| 127216061 | 12721606 | Condition aggravated | |
| 127216061 | 12721606 | Hypercalcaemia | |
| 127216061 | 12721606 | Milk-alkali syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |